Clinical outcome of immunonutrition in a heterogeneous intensive care population
- 356 Downloads
To study the effect of a high-protein enteral formula enriched with arginine, glutamine, and antioxidants and containing ω3 fatty acids and a mixture of fibers, on the clinical outcome of a heterogeneous intensive care (ICU) population.
Design and setting
A randomized, prospective, double blind, controlled, two-center clinical trial in two intensive care units in The Netherlands.
Patients and participants
A total of 597 adult ICU patients expected to require enteral tube feeding for more than 2 days were randomized to receive immunonutrition or an isocaloric control formula.
Patients received either the immunonutrition or the control feed.
Measurements and results
Intention-to-treat and per-protocol analyses showed no statistically significant difference in clinical outcome parameters between the two groups. Results of the intention-to-treat analysis in control vs. immunonutrition were: median ICU length of stay in days, 8.0 (IQR 5.0–16.0) vs. 7.0 (4.0–14.0); median hospital length of stay in days, 20.0 (IQR 10.0–34.0) vs. 20.0 (10.0–35.0); median days of ventilation, 6.0 (IQR 3.0–12.0) vs. 6.0 (IQR 3.0–12.0); ICU mortality, 26.8% vs. 28.2%; in-hospital mortality, 36.4% vs. 38.5%; infectious complications, 41.7% vs. 43.0%
The results of this largest randomized, controlled trial found that in the general ICU population immunonutrition has no beneficial effect on clinical outcome parameters. These results are consistent with the literature that is currently available.
KeywordsImmunonutrition Arginine ω3 Fatty acids Intensive care Clinical outcome Clinical trial
The authors thank Marianne van Hengel, Gerdien Melis, and Annette Coenen and all the ICU dieticians, nurses, and secretaries of both participating hospitals. We also thank Prof. R. Westendorp for his statistical consultation. Nutricia N.V. (The Netherlands) kindly provided the study products.
- 1.Braunschweig CL, Levy P, Sheean PM, Wang X (2001) Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr 74:534–542Google Scholar
- 2.DeWitt RC, Kudsk KA (1998) Enteral nutrition. Gastroenterol Clin North Am 27:371–386Google Scholar
- 3.Boelens PG, Nijveldt RJ, Houdijk AP, Meijer S, van Leeuwen PA (2001) Glutamine alimentation in catabolic state. J Nutr 131:2569S-2577SGoogle Scholar
- 6.Grimm H, Mayer K, Mayser P, Eigenbrodt E (2002) Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Br J Nutr 87 [Suppl 1]:S59–S67Google Scholar
- 8.Newsholme P (2001) Why is L-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection? J Nutr 131:2515S-2522SGoogle Scholar
- 9.Alexander JW (2002) Nutritional pharmacology in surgical patients. Am J Surg 183:349–352Google Scholar
- 10.Bower RH, Cerra FB, Bershadsky B, Licari JJ, Hoyt DB, Jensen GL, Van Buren CT, Rothkopf MM, Daly JM, Adelsberg BR (1995) Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med 23:436–449CrossRefGoogle Scholar
- 13.Dent DL, Heyland D, Levy H, Martindale R, Tayek J, Schloerb P, Kelly MJ (2003) Immunonutrition may increase mortality in critically ill patients with pneumonia: results of a randomized trial. Crit Care Med 30:A17Google Scholar
- 18.Montejo JC, Zarazaga A, Lopez-Martinez J, Urrutia G, Roque M, Blesa AL, Celaya S, Conejero R, Galban C, Garcia de Lorenzo A, Grau T, Mesejo A, Ortiz-Leyba C, Planas M, Ordonez J, Jimenez FJ (2003) Immunonutrition in the intensive care unit. A systematic review and consensus statement. Clin Nutr 22:221–233CrossRefGoogle Scholar
- 20.Heyland DK, Samis A (2003) Does immunonutrition in patients with sepsis do more harm than good? Intensive Care Med 29:669–671Google Scholar
- 21.Kieft H, Roos A, Bindels A, van Drunen J, Hofman Z (2003) Clinical outcome of an immune enhancing diet in a heterogeneous intensive care population. Crit Care Med 31:A82Google Scholar
- 22.Roos A, Kieft J, van Drunen J, Bindels J, Hofman Z (2003) Gender differences in clinical outcome of an immune enhancing diet in ICU patients: a hypothesis. Crit Care Med 31:A7Google Scholar
- 23.Casati A, Colombo S, Leggieri C, Muttini S, Capocasa T, Gallioli G (1996) Measured versus calculated energy expenditure in pressure support ventilated ICU patients. Minerva Anestesiol 62:165–170Google Scholar
- 24.Horan TC, Gaynes RP, Martone WJ (1992) CDC definitions of nosocomial surgical site infections, a modification of CDC definitions of surgical wound infections. Am J Infect Control 20:271–274Google Scholar
- 26.Veterans Affairs Total Parenteral Nutrition Cooperative Study Group (1991) Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325:525–532Google Scholar
- 27.Murray JF, Matthay MA, Luce JM, Flick MR (1988) An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 38:720-723Google Scholar
- 31.Lewis JA, Machin D (1993) Intention to treat—who ishould use ITT? Br. J. Cancer 68:647–650Google Scholar
- 32.Lee YJ, Ellenberg JH, Hirtz DG, Nelson KB (1991) Analysis of clinical trials by treatment actually received: is it really an option? Stat Med 10:1595–1605Google Scholar
- 33.(2001) Consensus recommendations from the US summitt on immune-enhancing enteral therapy. J Parenter Enteral Nutr 25:S61–S63Google Scholar
- 34.McCowen KC, Bistrian BR (2003) Immunonutrition: problematic or problem solving? Am J Clin Nutr 77:764–770Google Scholar
- 35.Heyland DK, Novak F (2001) Immunonutrition in the critically ill patient: more harm than good? J Parenter Enteral Nutr 25:S51–S55Google Scholar
- 38.Wohltmann CD, Franklin GA, Boaz PW, Luchette FA, Kearney PA, Richardson JD, Spain DA (2001) A multicenter evaluation of whether gender dimorphism affects survival after trauma. Am J Surg 181:297–300Google Scholar
- 39.Knudson MM, Lieberman J, Morris JA Jr, Cushing BM, Stubbs HA (1994) Mortality factors in geriatric blunt trauma patients. Arch Surg 129:448–453Google Scholar
- 40.Napolitano LM, Greco ME, Rodriguez A, Kufera JA, West RS, Scalea TM (2001) Gender differences in adverse outcomes after blunt trauma. J Trauma 50:274–280Google Scholar
- 41.Mostafa G, Huynh T, Sing RF, Miles WS, Norton HJ, Thomason MH (2002) Gender-related outcomes in trauma. J Trauma 53:430–434Google Scholar
- 42.Jacobsen SJ, Goldberg J, Miles TP, Brody JA, Stiers W, Rimm AA (1992) Race and sex differences in mortality following fracture of the hip. Am J Public Health 82:1147–1150Google Scholar
- 45.Merimee TJ, Rabinowtitz D, Fineberg SE (1969) Arginine-initiated release of human growth hormone. Factors modifying the response in normal man. N Engl J Med 280:1434–148Google Scholar
- 46.Bereket A, Lang CH, Wilson TA (1999) Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Horm Metab Res 31:172–181Google Scholar
- 49.Lynch EA, Dinarello CA, Cannon JG (1994) Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. J Immunol 153:300–306Google Scholar
- 50.Pacifici R, Rifas L, McCracken R, Vered I, McMurtry C, Avioli LV, Peck WA (1989) Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci U S A 86:2398–2402Google Scholar